Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
Sampedro F, Martnez-Horta S, Horta-Barba A, Grothe MJ, Labrador-Espinosa MA, Jess S, Adarmes-Gmez A, Carrillo F, Puig-Davi A, Lora FR, Barber MA (2022) Increased homocysteine levels correlate with cortical structural damage in Parkinsons disease
[16] Elevated levels following injection may persist for up to two weeks and should be considered when interpreting test results
[1] Picomolar activity is unusual for a small peptide and suggests high-affinity receptor-mediated signaling, though the specific receptor for GHK-Cu has never been identified